Veracyte is a pioneering genomic diagnostics company. Our tests are dramatically improving clinical outcomes for patients by resolving inconclusive results from traditional diagnostic methods. We ask the right questions to resolve ambiguity and bring assurance to light, rendering tens of thousands of costly and unnecessary surgeries truly unnecessary. We are giving patients a clearer path forward.Through scientific rigor we employ the best tools, best science and best minds to create tests that enable a more accurate diagnosis without the need for risky, costly and often unnecessary surgery. Veracyte consistently brings to bear evidence that is unprecedented in genomic tests, thereby changing today's clinical practice standards. We are making a difference in the lives of physicians and patients. We are doing something real.
|
|
|
|
|
501-1,000 employees
View all Veracyte, Inc. employees
|
|
|
biotechnology
|
|
|
6000 Shoreline Court,South San Francisco,CA,US
|
|
|
2008
|
|
|
Afirma® Thyroid Fna Analysis, Percepta® Bronchial Genomic Classifier, Envisia™ Genomic Classifier
|
Elizabeth Vega is the CEO of Veracyte, Inc.. To contact Elizabeth Vega email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.